Notably, from the integrated analysis of the TMAs we found that AKT activation was more frequently observed in tumours showing aberrant expression of more than a single gene within the PI3K pathway (PTEN loss, or overexpression of AKT1, AKT2, p110α respectively). This evidence concerns the gene AKT1 and neoplasm.